HosmartAI will create a common open Integration Platform with the necessary tools to facilitate and measure the benefits of integrating digital technologies (robotics and AI) in the healthcare system. A central hub will offer multifaceted lasting functionalities (Marketplace, Co-creation space, Benchmarking) to healthcare stakeholders, combined with a collection of methods, tools and solutions to integrate and deploy AI-enabled solutions. The Benchmarking tool will promote the adoption in new settings, while enabling a meeting place for technology providers and end-users.

VITALISE opens up Living Lab Infrastructures as a means to facilitate and promote research activities in the Health and Wellbeing domain in Europe and beyond by enabling in-person Transnational Access to 17 Living Lab research infrastructures and by supporting remote digital access to datasets (Virtual Access) of rehabilitation, transitional care and everyday life activities through harmonized processes and common tools.

URBANOME aims at building a common EU Framework for evaluating comprehensively multi-sector policies in urban settings supporting the “Health in all Policies” approach of WHO. In this light the overall objective of URBANOME is to promote urban health, wellbeing and liveability, through systematically integrating health concerns in urban policies and the activities of urban citizens, on the basis of detailed and comprehensive evidence on environmental health determinants, the spatial distribution of these in the city, and the social distribution of their impact among different population groups, accounting for different life styles and behaviours. Integration of health concerns, environmental stressors and social equality in public and private activities help alleviate a wide range of contemporary urban challenges, specifically social cohesion and health inequality, and promote the transition of European cities to sustainable, climate proof, smart and inclusive urban economies.

URBANOME brings together the complete set of environmental, social, and functional features of a city in an integrative analytical framework that would facilitate the identification of the main determinants of urban health and wellbeing and support co-creation and testing of policies and precision interventions designed to improve urban health and wellbeing through Urban Living Labs. The URBANOME approach will be applied through pilots built by the Urban Living Labs in Aarhus, Athens, Aberdeen, Madrid, Milan, Ljubljana, Stuttgart, Paris and Thessaloniki tackling various levels of environmental exposures, age-dependent susceptibility windows, inter-individual variability, gender differentiation of exposure, and socio-economic disparities. These will allow us to draw conclusions regarding the determinants of urban health and wellbeing that will be translated into evidence– based policy recommendations considering socio-economic and environmental factors leading to urban health inequalities. URBANOME is part of the European Cluster on Urban Health which includes other research projects funded in the frame of the same call.

LifeChamps aims at shifting the discrimination barrier for older cancer patients through the integration of different clinical and digital tools such as PROMs, PREMs, symptomatic and geriatric measures, mHealth and wearables, machine learning and artificial intelligence algorithms for Big Data. As its end result, Lifechamps will develop a novel, sophisticated and multifaceted clinical decision support tool for a comprehensive geriatric assessment.

SHAPES (Smart and Healthy Ageing through People Engaging in Supportive Systems) is a project funded by the EU Horizon 2020 programme and involves 36 partners from 14 countries: Belgium, Czech Republic, Cyprus, Finland, France, Germany, Greece, Ireland, Italy, Norway, Portugal, Spain, Sweden and United Kingdom.

Due to the increased incidence, prevalence and mortality of chronic diseases and multimorbidity, the need of palliative care (PC) resources is a challenge for health and social care systems. However, currently, access to PC remains inconsistent and, due to the ageing population, it is expected an increase in the rate of people requiring this kind of care over the next 25 years.

In spite of the continuous development of new drugs that target molecular mechanisms
responsible for generating epileptic seizures, approximately 25% of the patients with epilepsy are
proven medically resistant. These patients should be evaluated for surgery to remove the area
responsible for generating the attacks referred to as the epileptogenic zone (EZ). Surgical
outcomes strongly depend on the accuracy of the recognition of the EZ, which is currently
identified using a potential range of diagnostic tests. In such cases, long-term intracranial

SISCODE is a three-year project aiming to understand the co-creation phenomenon that is flourishing in Europe (in fab labs, living labs, social innovations, smart cities, communities and regions) and to analyse the context and conditions that support its effective introduction, scalability and replication. Eventually this will help bridge the gap between the process of co-constructing policies and their implementation. Co-creation will be analysed in particular in the light of Responsible Research and Innovation and Science, technology and innovation policies.